The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction ...

Jim Januzzi, MD, outlines a multitude of drug treatment options for heart failure revolving around patient ejection fraction (EF) status. Ryan Haumschild, PharmD, MS, MBA: As we start to transition ...

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...

Heart failure is a heterogeneous syndrome. Approximately 30–50% of patients with heart failure have normal or near normal left ventricle function. Several epidemiological studies confirm that the ...

Beta blockers have long been widely prescribed for patients with heart issues, but two new studies this week question the benefit of the therapies in certain patients with strong heart function. One ...

Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to ...

If you practice inpatient medicine, you've managed patients with heart failure with preserved ejection fraction (HFpEF). Formerly known as diastolic dysfunction, HFpEF is borderline ubiquitous on the ...

In contrast to the advances in therapy for systolic HF over the past three decades, which have improved mortality rates, no therapies have been proven to reduce mortality in patients with HFNEF (Table ...